Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Foamy virus vectors.

A Mergia1, M Heinkelein

  • 1Department of Pathobiology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA. Mergiaa@mail.vetmed.ufl.edu

Current Topics in Microbiology and Immunology
|August 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extract prepared from the leaves of Ocimum basilicum inhibits the entry of Zika virus.

Acta virologica·2019
Same author

Foamy virus--adenovirus hybrid vectors.

Gene therapy·2004
Same author

Tissue dynamics of CD8 lymphocytes that suppress viral replication in cats infected neonatally with feline immunodeficiency virus.

The Journal of infectious diseases·2001
Same author

Phenotypic analysis of the sensitivity of HIV-1 to inhibitors of the reverse transcriptase, protease, and integrase using a self-inactivating virus vector system.

Journal of medical virology·2001
Same author

A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity.

Journal of virology·2001
Same author

Thymic lesions in cats infected with a pathogenic molecular clone or an ORF-A/2-deficient molecular clone of feline immunodeficiency virus.

Journal of virology·2001
Same journal

Resolution Biology in Soft Tissue Joint Disease.

Current topics in microbiology and immunology·2026
Same journal

A 25+ Year Journey on Yeast-Regulated Cell Death Research.

Current topics in microbiology and immunology·2026
Same journal

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same journal

Resolution Pharmacology Targeting the Melanocortin System.

Current topics in microbiology and immunology·2026
Same journal

Resolution of Skeletal Muscle Inflammation: Role of Specialized Pro-resolving Lipid Mediators in the Recovery from Exercise, Injury, and Disease.

Current topics in microbiology and immunology·2026
Same journal

Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Strains.

Current topics in microbiology and immunology·2026
See all related articles

Foamy virus vectors offer a safe and efficient alternative for gene therapy delivery. These nonpathogenic vectors can transfer multiple genes into various cell types, overcoming limitations of current gene transfer methods.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Virology

Background:

  • Gene therapy holds promise for treating human diseases.
  • Effective gene delivery vehicles are crucial for successful gene therapy.
  • Current viral vectors face challenges in efficiency and safety.

Purpose of the Study:

  • To review foamy virus vector systems for gene therapy.
  • To highlight the advantages of foamy viruses over existing vectors.
  • To discuss recent advancements in foamy virus vector development.

Main Methods:

  • Review of foamy virus biology and replication.
  • Analysis of foamy virus vector design and capabilities.
  • Examination of transduction efficiency and host range.

Related Experiment Videos

Main Results:

  • Foamy viruses are nonpathogenic with a broad host range.
  • Distinct replication cycle offers advantages over retroviral vectors.
  • Foamy virus vectors can efficiently deliver multiple genes in vivo.

Conclusions:

  • Foamy virus vectors present a safe and efficient alternative for gene transfer.
  • Technical challenges in foamy virus vector design have been overcome.
  • These vectors show significant potential for diverse gene therapy applications.